Cargando…
Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
PANoptosis pathway gene sets encompassing pyroptosis, apoptosis, and necroptosis were identified from the MSigDB database. We analyzed the perturbations and crosstalk in the PANoptosis pathway in prostate adenocarcinoma (PRAD), including gene mutation, transcription, methylation, and clinical featur...
Autores principales: | Yi, Xianyanling, Li, Jin, Zheng, Xiaonan, Xu, Hang, Liao, Dazhou, Zhang, Tianyi, Wei, Qiang, Li, Hong, Peng, Jiajie, Ai, Jianzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400972/ https://www.ncbi.nlm.nih.gov/pubmed/37547288 http://dx.doi.org/10.1016/j.omtn.2023.07.010 |
Ejemplares similares
-
IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer
por: Yi, Xianyanling, et al.
Publicado: (2022) -
Vitamin E intake and multiple health outcomes: an umbrella review
por: Zhang, Tianyi, et al.
Publicado: (2023) -
Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine
por: Zheng, Xiaonan, et al.
Publicado: (2021) -
SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs
por: Xu, Hang, et al.
Publicado: (2022) -
Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma
por: Xu, Hang, et al.
Publicado: (2021)